Rezolute (RZLT) Cash & Equivalents (2010 - 2026)
Rezolute (RZLT) reported Cash & Equivalents of $11.2 million for Q1 2026, down 23.29% on a YoY basis from $14.6 million in Q1 2025, and down 6.23% sequentially from $11.9 million in Q4 2025.
Rezolute (RZLT) Cash & Equivalents (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 13 years of Cash & Equivalents data on file, last reported at $11.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 23.29% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (down 23.29% YoY), and the FY2025 full-year result was $94.1 million, up 33.68% from the prior year.
- Cash & Equivalents declined to $11.2 million in Q1 2026, from $11.9 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $154.3 million in Q3 2022 to a low of $5.9 million in Q1 2024.
- A 5-year average of $48.3 million and a median of $14.6 million in 2025 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents plunged 94.75% in 2023 and soared 338.99% in 2024, its largest moves.
- Tracing RZLT's Cash & Equivalents over 5 years: stood at $146.7 million in 2022, then sank by 91.48% to $12.5 million in 2023, then fell by 28.57% to $8.9 million in 2024, then surged by 33.72% to $11.9 million in 2025, then declined by 6.23% to $11.2 million in 2026.
- Business Quant data shows RZLT's Cash & Equivalents at $11.2 million in Q1 2026, $11.9 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 9.10 Mn |
| Jun 30, 2025 | 94.11 Mn |
| Mar 31, 2025 | 14.60 Mn |
| Dec 31, 2024 | 8.93 Mn |
| Sep 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 70.40 Mn |
| Mar 31, 2024 | 5.93 Mn |
| Dec 31, 2023 | 12.50 Mn |
| Sep 30, 2023 | 8.10 Mn |
| Jun 30, 2023 | 16.04 Mn |
| Mar 31, 2023 | 33.70 Mn |
| Dec 31, 2022 | 146.75 Mn |
| Sep 30, 2022 | 154.32 Mn |
| Jun 30, 2022 | 150.41 Mn |
| Mar 31, 2022 | 63.42 Mn |
| Dec 31, 2021 | 77.40 Mn |
| Sep 30, 2021 | 37.29 Mn |
| Jun 30, 2021 | 41.05 Mn |